Anja Sandström
Professor at Department of Medicinal Chemistry; Drug Design and Discovery
- Telephone:
- +46 70 167 97 76, +46 18 471 50 26
- E-mail:
- anja.sandstrom@ilk.uu.se
- Visiting address:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postal address:
- Box 574
751 23 UPPSALA
Biography
I earned a Master's degree in Pharmacy in 1997 and completed my PhD in medicinal chemistry in 2003, studying under Professor Anders Hallberg at Uppsala University. I started my career at the same university as a research scientist. I became an associate professor (docent) in 2009 and a university lecturer in 2011. In 2013, I spent time as a STINT fellow at Amherst College in Massachusetts, USA. Over the years, I've received several teaching awards from Uppsala University and the Pharmaceutical Student Union. In 2017, I was recognized as an excellent teacher, and in 2021, I was promoted to the position of Professor. I've also taken on various leadership roles, including Study Director and Deputy and Assistant Head of the Department of Medicinal chemistry. Currently, I serve as the Deputy Dean of Education at the Faculty of Pharmacy. My research primarily focuses on peptides and peptidomimetics in drug discovery, with a special interest in developing pharmaceutical compounds for infectious diseases.

Publications
Recent publications
Part of Antimicrobial Agents and Chemotherapy, p. 1-18, 2024
- DOI for Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
- Download full text (pdf) of Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
Part of European Journal of Medicinal Chemistry, 2024
- DOI for Design, synthesis, and in vitro biological evaluation of meta-sulfonamidobenzamide-based antibacterial LpxH inhibitors
- Download full text (pdf) of Design, synthesis, and in vitro biological evaluation of meta-sulfonamidobenzamide-based antibacterial LpxH inhibitors
Part of Journal of the American Chemical Society, p. 2905-2920, 2022
- DOI for Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
- Download full text (pdf) of Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
Part of European Journal of Medicinal Chemistry, 2021
- DOI for Antibacterial sulfonimidamide-based oligopeptides as type I signal peptidase inhibitors: Synthesis and biological evaluation
- Download full text (pdf) of Antibacterial sulfonimidamide-based oligopeptides as type I signal peptidase inhibitors: Synthesis and biological evaluation
Part of Antiviral Research, 2021
All publications
Articles in journal
Part of Antimicrobial Agents and Chemotherapy, p. 1-18, 2024
- DOI for Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
- Download full text (pdf) of Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
Part of European Journal of Medicinal Chemistry, 2024
- DOI for Design, synthesis, and in vitro biological evaluation of meta-sulfonamidobenzamide-based antibacterial LpxH inhibitors
- Download full text (pdf) of Design, synthesis, and in vitro biological evaluation of meta-sulfonamidobenzamide-based antibacterial LpxH inhibitors
Part of Journal of the American Chemical Society, p. 2905-2920, 2022
- DOI for Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
- Download full text (pdf) of Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
Part of European Journal of Medicinal Chemistry, 2021
- DOI for Antibacterial sulfonimidamide-based oligopeptides as type I signal peptidase inhibitors: Synthesis and biological evaluation
- Download full text (pdf) of Antibacterial sulfonimidamide-based oligopeptides as type I signal peptidase inhibitors: Synthesis and biological evaluation
Part of Antiviral Research, 2021
Part of European Journal of Pharmacology, 2021
Solid Phase Synthesis of Sulfonimidamide Pseudopeptides and Library Generation
Part of European Journal of Organic Chemistry, p. 3796-3807, 2020
- DOI for Solid Phase Synthesis of Sulfonimidamide Pseudopeptides and Library Generation
- Download full text (pdf) of Solid Phase Synthesis of Sulfonimidamide Pseudopeptides and Library Generation
Part of Journal of Biomolecular Structure and Dynamics, p. 5526-5536, 2020
- DOI for Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease
- Download full text (pdf) of Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease
Macrocyclic Peptidomimetics as Inhibitors of Insulin-Regulated Aminopeptidase (IRAP)
Part of RSC Medicinal chemistry, p. 234-244, 2020
Synthesis of Sulfonimidamide-Based Amino Acid Building Blocks with Orthogonal Protecting Groups
Part of European Journal of Organic Chemistry, p. 1045-1057, 2019
Part of Bioorganic & Medicinal Chemistry Letters, p. 2446-2450, 2018
Pan-NS3 protease inhibitors of hepatitis C virus based on an R3-elongated pyrazinone scaffold
Part of European Journal of Medicinal Chemistry, p. 453-464, 2018
Part of European Journal of Pharmaceutical Sciences, p. 533-540, 2017
Part of Organic Letters, p. 2873-2876, 2017
Part of European Journal of Pharmaceutical Sciences, p. 345-351, 2017
Part of Bioorganic & Medicinal Chemistry, p. 2603-2620, 2016
Part of Neuroscience, p. 112-119, 2015
Part of ChemMedChem, p. 455-460, 2015
Part of European Journal of Organic Chemistry, p. 213-219, 2015
Efficient and Selective Palladium-Catalysed C-3 Urea Couplings to 3,5-Dichloro-2(1H)-pyrazinones
Part of European Journal of Organic Chemistry, p. 978-986, 2015
Palladium-Catalyzed Carbonylation of Aryl Iodides with Sulfinamides
Part of European Journal of Organic Chemistry, p. 7069-7074, 2015
Part of Bioorganic & Medicinal Chemistry, p. 6595-6615, 2014
Part of ACS Medicinal Chemistry Letters, p. 1272-1277, 2014
Novel Peptidomimetic Hepatitis C Virus NS3/4A Protease Inhibitors Spanning the P2–P1′ Region
Part of ACS Medicinal Chemistry Letters, p. 249-254, 2014
Part of Journal of Medicinal Chemistry, p. 1790-1801, 2014
Part of European Journal of Pharmacology, p. 319-325, 2014
Part of Journal of Organic Chemistry, p. 12251-12256, 2013
Part of Journal of Medicinal Chemistry, p. 4953-4965, 2013
Part of Organic Letters, p. 1056-1059, 2013
Synthesis of functionalized furopyrazines as restricted dipeptidomimetics
Part of Tetrahedron, p. 3019-3029, 2012
Part of Molecular Pain, p. 85, 2011
- DOI for The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system
- Download full text (pdf) of The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system
Part of Bioorganic & Medicinal Chemistry, p. 4917-4927, 2011
The effect of substance P1-7 amide on nociceptive threshold in diabetic mice
Part of Peptides, p. 93-98, 2011
Discovery of Achiral Inhibitors of the Hepatitis C Virus NS3 Protease based on 2(1H)-pyrazinones
Part of Bioorganic & Medicinal Chemistry, p. 6512-6525, 2010
Hepatitis C protease inhibitors based on 2(1H)-pyrazinones
Part of Abstracts of Papers of the American Chemical Society, 2010
Part of Antiviral Therapy, p. 841-852, 2010
Part of Bioorganic & Medicinal Chemistry, p. 5413-5424, 2010
Discovery of Dipeptides with High Affinity to the Specific Binding Site for Substance P1-7
Part of Journal of Medicinal Chemistry, p. 2383-2389, 2010
Part of Organic and biomolecular chemistry, p. 2809-2815, 2009
Part of European Journal of Pharmaceutical Sciences, p. 556-563, 2009
Part of Peptides, p. 2418-2422, 2009
Small peptides mimicking substance P (1-7) and encompassing a C-terminal amide functionality
Part of Neuropeptides, p. 31-37, 2008
Part of Bioorganic & Medicinal Chemistry, p. 5590-5605, 2008
Hepatitis C Virus NS3 Protease Inhibitors Comprising a Novel Aromatic P1 Moiety
Part of Bioorganic & Medicinal Chemistry, p. 2955-2967, 2008
Part of Bioorganic & Medicinal Chemistry, p. 4057-4068, 2007
Mechanistic studies of electrophilic protease inhibitors of full length hepatic C virus (HCV) NS3
Part of Journal of enzyme inhibition and medicinal chemistry (Print), p. 191-199, 2007
Phenylglycine as a Novel P2 Scaffold in Hepatitis C Virus NS3 Protease Inhibitors
Part of Bioorganic & Medicinal Chemistry, p. 1448-1474, 2007
Part of The FEBS Journal, p. 5979-5986, 2007
Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3
Part of Antiviral Therapy, p. 733-740, 2007
Part of Bioorganic & Medicinal Chemistry, p. 544-559, 2006
Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors
Part of Biochimica et Biophysica Acta, p. 51-59, 2004
Part of Bioorganic & Medicinal Chemistry, p. 2551-2568, 2003
Part of Bioorganic & Medicinal Chemistry, p. 3915-22, 2002
Part of Journal of Medicinal Chemistry, p. 1767-1777, 2002
Part of Bioorganic & Medicinal Chemistry Letters, p. 203-206, 2001
An Improved Procedure for N- to C-Directed (Inverse) Solid-Phase Peptide Synthesis
Part of Journal of combinatorial chemistry, p. 496-507, 2000
Articles, review/survey
From the Anti-Nociceptive Substance P Metabolite Substance P (1-7) to Small Peptidomimetics
Part of Current protein and peptide science, p. 1038-1048, 2018
New developments in the discovery of agents to treat hepatitis C
Part of Current Topics in Medicinal Chemistry, p. 533-562, 2008
Chapters in book
Part of In Neuropeptides in Neuroprotection and Neuroregeneration., p. 253-270, Taylor & Francis Group, 2012